Infection | Consideration |
---|---|
HIV | Baseline testing. Follow up test at 6 weeks and 12 weeks. Samples and their results taken at baseline and subsequently may be legally presentable. Consider referral for post-exposure prophylaxis if seen within 72 hours of exposure. |
Syphilis | Baseline testing. Follow up in 6 weeks and 12 weeks. If clinical suspicion of syphilis, refer to the syphilis guideline. |
Hepatitis B | Baseline testing. Repeat HBsAg at 6 weeks and 12 weeks if anti-HBs negative. Consider hepatitis B immunoglobulin if non-immune, no history of vaccination or unknown status. This should be given within 72 hours of potential exposure, along with the hepatitis B vaccine within 14 days. Ensure vaccination schedule is completed if needed. |
Chlamydia | Test any orifice which has been penetrated. Consider self-collection of samples for testing. Initial screening and repeat after 2 weeks or earlier if symptomatic. NAAT is highly sensitive and may detect early infection as a result. |
Gonorrhoea | Test any orifice which has been penetrated. Consider self-collection of samples for testing. Initial screening and repeat after 2 weeks or earlier if symptomatic. NAAT is highly sensitive and may detect early infection as a result. If NAAT test result is positive, take swab at relevant site(s) for culture, before treatment. |
Trichomoniasis | Initial screening and repeat after 2 weeks or earlier if symptomatic. NAAT is highly sensitive and may detect early infection as a result. |
HBsAg – Hepatitis B surface antigen Anti-HBs – Hepatitis B surface antibody NAAT – Nucleic Acid Amplification Test |
Clinician collected | Self-collection
Make arrangements for the provision of results to the person.
If test results are positive, refer to STI management section for advice on:
Even if all test results are negative, use the opportunity to:
STI testing is offered at baseline or at follow-up for 100% of cases of adult sexual assault.